MADRID, Oct. 28, 2024 /PRNewswire/ — START Cancer Research Center (“START”), a world leader in early stage cancer clinical trials, today announced a new collaboration with Fundación Rioja Salud. announced a strategic partnership. (i) the promotion and protection of health; (ii) training, education, research, development and innovation in health sciences and biotechnology, including drug development and medical education; and (iii) the integration of research and clinical practice in healthcare settings. – Rioja state. This partnership marks the establishment of an additional START early stage unit in La Rioja and expands START’s robust network, which currently includes eight clinical trial sites and a team of 25 principal investigators (PIs) around the world .
START Cancer Research Center and Rioja Salud Foundation announce new partnership to further expand access to early clinical trials in Spain
The expansion builds on START’s existing footprint in Spain, including two locations in Madrid at Sanchinaro Hospital and Jiménez Díaz University Hospital, and a location at Nou Delfos Hospital in Barcelona. This announcement follows START’s June announcement of a partnership with Northwell Health to establish two new early-stage clinical trial sites in New York.
The new START site will be co-located with San Pedro University Hospital, which admits 1,800 new cancer patients annually. Importantly, it is located in the heart of the northern regions of Aragon, Pais Vasco, Navarra, Castile and León, Cantabria and Asturias. These states have a combined population of 8.1 million people, many of whom live more than 320 miles from the nearest public oncology trial sites, Madrid and Barcelona. “We are excited to be working with START,” said Juan Carlos Oliva Pérez, CEO of the Rioja Salud Fund. “It will enable us to provide front-line cancer research and treatment options.”
“This partnership with Rioja Salud is an important milestone in our mission to enhance access to cutting-edge cancer treatments,” said START Chairman and CEO Nick Slack. said. “Expanding our network into La Rioja will not only allow us to reach more patients, but also strengthen our commitment to pioneering cancer research and treatment.”
Dr. Emiliano Calvo, President of START Europe, also commented on the expansion: “The establishment of a new early-stage unit in La Rioja demonstrates our dedication to advancing cancer care for all communities in Spain and the region. This is proof that we are working together with Rioja.” Mr. Salud, we aim to bring innovative treatments closer to patients and combine our expertise to make a meaningful difference in the fight against cancer. ”
The new START early stage unit in La Rioja is expected to expand the range of cancer clinical trials available to patients in Spain and complement existing facilities in Madrid and Barcelona. This initiative highlights the collaborative efforts of both organizations to improve patient outcomes and advance global cancer research.
About START Cancer Research Center
With deep roots in regional oncology centers around the world, START Cancer Research Centers provide access to specialized preclinical and early-stage clinical trials of novel cancer drugs. The START Clinical Trials Facility has conducted more than 1,000 early-stage clinical trials, including 43 treatments approved by the FDA or EMA. START represents the world’s largest roster of principal investigators (PIs) across eight clinical trial sites. START is dedicated to accelerating the transition from clinical trials to treatment, delivering hope to patients, families, and physicians around the world. For more information, please visit STARTresearch.com.
About Rioja Salud Foundation
Fundación Rioja Salud was established as a foundation on December 3, 2001 and became operational in June 2002. Since 2008, it has hosted the La Rioja Biomedical Research Center (CIBIR), an organization dedicated to promoting health science research in La Rioja. La Rioja. With more than 200 staff, FRS manages and advances biomedical research conducted in the region and provides advanced medical resources and services.
START Media Contact:
Lauren Panko (email protected) +1 609 216 4920
Fundación Rioja Salud Media Contact:
Ander LaGuardia Baron (email protected) +34 941 29 84 94
Source START Cancer Research Center
Want your company’s news featured on PRNEWSWIRE.COM?
Over 440,000
newsroom and
influencer
9k+
digital media
outlet
Over 270,000
journalist
opt-in
